Board of Directors

Michael Redmond

Non-Executive Chairman

Committee Membership

Nomination (Chairman), Remuneration

Background

Michael joined the Group as a Non-Executive Director in April 2001, and was appointed Chairman in July 2002. He has extensive pharmaceutical industry experience having begun his career with Glaxo and through senior positions with Schering Plough Corporation. In 1991, he joined Fisons plc and in 1993 was appointed to the Board as Managing Director of the Group's Pharmaceuticals Division. Michael left Fisons in 1995 following its takeover by RPR.

External appointments

In November 2009, Michael was appointed Chairman of Abcam PLC, an AIM listed company, where he had previously held the post of Deputy Chairman (appointed February 2009).

Ian Page

Chief Executive Officer

Committee Membership

Not applicable

Background

Ian joined NVS at its formation in 1989. He was also part of the MBO in 1997. In 1998, he was appointed Managing Director at NVS. He joined the Board in 1997 and became Chief Executive in November 2001. Ian has played a key role in the development of the Group's growth strategy. Prior to joining the Company, he gained extensive knowledge and experience through various positions he held within the pharmaceutical and veterinary arena.

External appointments

In October 2010 Ian was appointed as Non-Executive Chairman of Sanford DeLand Asset Management.

Anne-Francoise Nesmes

Chief Financial Officer

Committee Membership

Not applicable

Background

Anne-Francoise was appointed Chief Financial Officer in April 2013. Prior to joining the Company, Anne-Francoise worked at GlaxoSmithKline ("GSK") for over 15 years, where she held a number of finance roles including Senior Vice-President, Finance, of the global vaccines business unit based in Belgium. With GSK, Anne-Francoise developed her experience in a variety of roles including internal audit, corporate planning, commercial finance and between 2003 and 2006 was Vice-President Finance Controller for Europe. Prior to this Anne-Francoise held finance roles with John Crane, Tetra Pak, ADP and Caterpillar UK.

External appointments

None.

Ed Torr

Business Development Director

Committee Membership

Not applicable

Background

Ed joined NVS as Sales Director in 1997 and was appointed Managing Director of Arnolds and Dales in 1998. He was appointed Development Director in 2003 and Managing Director of Dechra Veterinary Products EU in January 2008, following completion of the acquisition of VetXX. In May 2012 on the completion of the acquisition of Eurovet Animal Health BV, Ed reverted to his historical position within Dechra as Business Development Director. Prior to joining the Group, he worked within the animal healthcare sector for a number of companies including ICI, Wellcome and Alfa Laval Agri.

External appointments

None.

Tony Griffin

Managing Director, Dechra Veterinary Products EU

Committee Membership

Not applicable

Background

Tony was appointed Managing Director of DVP EU in May 2012 following the acquisition of Eurovet Animal Health BV from AUV Holding B.V. He joined the AUV Group in 1993 as Director of Exports, having previously worked at Norbrook Laboratories and Moy Park. Tony was promoted to Managing Director of Eurovet in 1996 and in 2006 became the CEO of the AUV Group.

External appointments

None.

Neil Warner

Senior Independent Non-Executive Director

Committee Membership

Audit (Chairman), Nomination, Remuneration

Background

Neil joined the Board in May 2003. He was Finance Director at Chloride Group PLC, a position he held for 14 years until its acquisition by Emerson Electric Co. Prior to this, Neil spent six years at Exel PLC (formerly Ocean Group PLC and acquired by Deutsche Post in December 2005) where he held a number of senior posts in financial planning, treasury and control. He has also held senior positions in Balfour Beatty PLC (formerly BICC Group plc), Alcoa and PricewaterhouseCoopers.

External appointments

In February 2011 Neil was appointed Non-Executive Director and Chair of the Audit Committee of Vectura Group plc, a product development company focused on the development of a range of inhaled therapies, principally for the treatment of respiratory diseases. He is also Non-Executive Chairman of Enteq Upstream plc, a specialist reach and recovery products and technologies provider to the upstream oil and gas services market, a post he has held since 26 May 2011.

Dr Christopher Richards

Non-Executive Director

Committee Membership

Remuneration (Chairman), Audit, Nomination

Background

Chris joined the Group as a Non-Executive Director in December 2010. He is Chairman of Arysta LifeScience Corporation, having previously been appointed its President and Chief Executive Officer from 2004 to 2009. Arysta is a Japan-domiciled international company, developing and marketing crop protection products in more than 125 countries worldwide. Before joining Arysta, Chris spent 20 years in international management and leadership roles with Syngenta Crop Protection and its predecessor companies.

External appointments

Chris holds a number of Non-Executive Directorships including Cibus Global Limited (appointed November 2011), and he is Chairman of Oxitec Limited (appointed January 2012) and Plant Health Care PLC (appointed July 2012).

Julian Heslop

Non-Executive Director

Committee Membership

Audit, Nomination, Remuneration

Background

Julian joined the Board in January 2013. He served as Chief Financial Officer of GlaxoSmithKline PLC between 2005 and 2011, having previously been appointed its Senior Vice President, Operations Controller between 2001 and 2005 and as Financial Controller of Glaxo Wellcome PLC between 1998 and 2000. Prior to this, Julian had senior finance roles at Grand Metropolitan PLC and Imperial Brewing and Leisure. He is a Fellow of the Institute of Chartered Accountants in England and Wales.

External appointments

Julian was appointed as a Non-Executive Director at Revolymer PLC in July 2012 and is their Audit Committee Chairman. He is also Chairman of the Audit Committee of the Royal Academy of Arts.

Ishbel Macpherson

Non-Executive Director

Committee Membership

Audit, Nomination, Remuneration

Background

Ishbel joined the Group as a Non-Executive Director in February 2013. She has over 20 years' experience as an investment banker, specialising in UK mid-market corporate finance. She was Head of UK Emerging Companies Corporate Finance at Dresdner Kleinwort Benson from 1999 to 2005, having previously worked at Hoare Govett and Barclays de Zoete Wedd.

External appointments

Ishbel is currently Non-Executive Chairman of Speedy Hire PLC, a position which she has held since January 2011 (having been appointed to the Board of Speedy Hire in 2007). Ishbel is also a Non-Executive Director at Dignity plc and, previously, at May Gurney Integrated Services plc from 2010 to 2013.

Zoe Goulding

Company Secretary and Solicitor

Background

Zoe was appointed as Company Secretary in July 2007. She qualified as a solicitor in April 2000. Prior to joining the Group she worked at Eversheds LLP and Brammer plc.

External appointments

None.